EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Nrf2 Signaling in Friedreich’s Ataxia Cardiomyopathy: Sex-Dependent Therapeutic Responses to Dimethyl Fumarate and Omaveloxolone

Francisco Figueroa, Lili Salinas, Claire B. Montgomery-Bowie, Ryan Sellers, Landon Sims, Garrett P. Cox, Sascha L. Golove, Phung N. Thai, Nipavan Chiamvimonvat, Gino Cortopassi, Elena N. Dedkova

Antioxidants · 17.11.2026 · 15 (11) · 1490

DOI: 10.3390/antiox15111490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 17.11.2026. Verfasst von Francisco Figueroa und 10 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, FARA Research Award, American Heart Association Transformational Research Project.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Friedreich’s ataxia (FA) is a progressive neurodegenerative disorder frequently associated with hypertrophic cardiomyopathy and heart failure, a major cause of mortality. FA results from frataxin deficiency, leading to mitochondrial dysfunction, impaired iron–sulfur cluster biogenesis, and oxidative stress. We examined the effect of two clinically relevant Nrf2 activators, dimethyl fumarate (DMF) and omaveloxolone (OMAV), on their ability to restore cardiac function in an inducible and reversible frataxin-knockdown (FXNKD) mouse model of FA. FXNKD mice developed a heart failure with preserved ejection fraction–like phenotype, characterized by left ventricular wall thickening, impaired diastolic relaxation, and reduced stroke volume, with more severe remodeling observed in males. Both treatments activated canonical Nrf2 signaling, confirming target engagement. DMF partially improved cardiac function in males, increasing stroke volume, enhancing metabolic flexibility, and restoring mitochondrial enzyme activity; however, diastolic dysfunction persisted. OMAV treatment was associated with female-specific electrophysiological abnormalities, including increased arrhythmic burden and reduced J-wave amplitude, with persistent fibrotic remodeling. Both treatments attenuated region-specific cardiomyocyte atrophy in FXNKD males and females. These findings suggest that Nrf2 activation alone is insufficient to reverse FA-associated cardiomyopathy and reveal sex-dependent therapeutic responses. Further investigation of complementary treatment strategies may help address persistent cardiac dysfunction and remodeling in FA.

Förderung

  • National Institutes of Health
  • FARA Research Award
  • American Heart Association Transformational Research Project
  • University of California Davis CRCF Pilot & Feasibility Award
  • University of California Innovative Development Award
  • Basic & Translational Cardiovascular Science
  • Diversity Supplement

Zitieren

APA

Figueroa, F., Salinas, L., Montgomery-Bowie, C. B., Sellers, R., Sims, L., Cox, G. P., Golove, S. L., Thai, P. N., Chiamvimonvat, N., Cortopassi, G., & Dedkova, E. N. (2026). Targeting Nrf2 Signaling in Friedreich’s Ataxia Cardiomyopathy: Sex-Dependent Therapeutic Responses to Dimethyl Fumarate and Omaveloxolone. Antioxidants, 15(11), 1490. https://doi.org/10.3390/antiox15111490

Vancouver

Figueroa F, Salinas L, Montgomery-Bowie CB, Sellers R, Sims L, Cox GP, et al. Targeting Nrf2 Signaling in Friedreich’s Ataxia Cardiomyopathy: Sex-Dependent Therapeutic Responses to Dimethyl Fumarate and Omaveloxolone. Antioxidants. 2026;15(11):1490. doi:10.3390/antiox15111490

BibTeX
@article{Figueroa2026,
  author = {Figueroa, Francisco and Salinas, Lili and Montgomery-Bowie, Claire B. and Sellers, Ryan and Sims, Landon and Cox, Garrett P. and Golove, Sascha L. and Thai, Phung N. and Chiamvimonvat, Nipavan and Cortopassi, Gino and Dedkova, Elena N.},
  title = {Targeting Nrf2 Signaling in Friedreich’s Ataxia Cardiomyopathy: Sex-Dependent Therapeutic Responses to Dimethyl Fumarate and Omaveloxolone},
  journal = {Antioxidants},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {1490},
  doi = {10.3390/antiox15111490}
}
Kostenlos starten →